China’s central bank asked payments giant Ant Group Co Ltd to rectify financial regulatory violations, including in its credit, insurance, and wealth management businesses, and overhaul its credit rating business to protect personal information.
The announcement by People’s Bank of China (PBOC) Vice Governor Pan Gongsheng is the latest blow to Ant Group's founder and controlling shareholder Jack Ma.
According to Pan, should set up a separate holding company to ensure capital adequacy and regulatory compliance. He added that Ant Group should be fully licensed to operate its personal credit business, not engage in unfair competition, and be more transparent about its third-party payment transactions.
Officials from the PBOC and other Chinese banking, securities and foreign exchange regulators met with Ant representatives on Saturday, where they pointed issues with Ant, including its defiance of regulatory demands, illegal regulatory arbitrary, poor corporate governance, the use of its market advantage to squeeze out competitors and harming consumers’ legal interests.
Ant said it would fully implement regulatory requirements through a “rectification” working group.
Last month, Chinese regulators abruptly suspended Ant’s blockbuster $37 billion initial public offerings in Shanghai and Hong Kong, days after the country’s antitrust authorities launched a probe into Ma’s e-commerce conglomerate Alibaba Group Holding Ltd.
Ma had publicly criticized China's regulatory system in October for stifling innovation.


SK Hynix Q2 Profit Hits Record as AI Memory Chip Demand Fuels Growth
Stellantis Sells Free2move Car-Sharing Business to Mutares to Strengthen Core Auto Strategy
Serica Energy to Acquire Pharos Energy for £145.7M, Sending PHARP Shares Soaring
CATL Shares Jump as $5.6 Billion Buyback Signals Confidence in Long-Term Growth
Nvidia Invests $1 Billion in Naver as South Korea AI Data Center Expansion Gains Momentum
Nvidia Eyes $250B Guarantee for OpenAI’s Massive Ohio AI Data Center Project
ASML, Applied Materials Slide as China DUV Chip Equipment Breakthrough Sparks Market Jitters
Philips Shares Slide 10% Despite Earnings Beat as Weak Orders Raise Growth Concerns
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
TSMC Gradually Restarts Japan Chip Plant After Kumamoto Earthquake
Unilever Raises 2026 Sales Outlook After Strong Q2 Volume Growth
Standard Chartered Beats Profit Forecasts as First-Half Earnings Rise 9%
CXMT IPO Debut in Shanghai Puts $85.5 Billion Chipmaker in Spotlight
Johnson & Johnson Proposes $5.5 Billion Talc Settlement to Resolve U.S. Ovarian Cancer Lawsuits
Galp Shares Fall After Q2 EBITDA Miss Despite Profit Beat and Higher Dividend
BHP, Port Hedland Unions Fail to Reach Wage Deal as Negotiations Continue 



